Ingenol mebutate (IngMeb) 0.015% or 0.05% is approved for actinic keratosis (AK) areas ≤25 cm2; some patients require treatment of larger fields.
Continue Reading→Porphyria cutanea tarda (PCT) is a rare hepatocutaneous disease whose prognosis is largely unknown.
Continue Reading→Mycosis fungoides (MF) is associated with increased risk of second primary hematologic malignancies, but its association with second primary solid tumors is less well characterized.
Continue Reading→Significant unmet need exists for long-term treatment of moderate-to-severe atopic dermatitis (AD).
Continue Reading→